GlassScriptPhysician profile
Leah Najima
NPI 1518952712
$3,053.70
in general payments reported to CMS, 2019-2025
22 companies · $480 in 2025
The $480 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $112 · 2021: $379 · 2022: $442 · 2023: $672 · 2024: $382 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,449 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,448.83 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $660.15 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $571.72 | 2022-2025 | |
| Astellas Pharma US INC | $475.64 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $199.83 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $154.68 | 2019-2024 | Gardasil, Gardasil 9 |
| Baxter Healthcare | $132.59 | 2025 | Perclot |
| Bayer Healthcare Pharmaceuticals INC. | $127.64 | 2019-2025 | |
| Hologic Sales and Service, LLC | $109.32 | 2019 | |
| Myovant Sciences INC. | $106.00 | 2021-2022 | |
| Evofem Biosciences, INC. | $79.88 | 2024-2025 | Phexxi, Solosec, Phexx |
| Allergan, INC. | $76.71 | 2019-2020 | |
| Daiichi Sankyo INC. | $54.07 | 2019-2021 | |
| Intuitive Surgical, INC. | $53.17 | 2019 | |
| Amag Pharmaceuticals, INC. | $50.99 | 2019 | |
| Sumitomo Pharma America, INC. | $44.01 | 2023-2024 | Myfembree |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $33.53 | 2019 | |
| Octapharma USA, INC. | $25.50 | 2025 | Fibryga |
| Aspira Women'S Health INC | $24.03 | 2024 | Ova1 |
| Alydia Health | $22.59 | 2021 | |
| Roche Diagnostics Corporation | $18.54 | 2021 | |
| Sage Therapeutics, LLC | $16.58 | 2024 | |
| Agile Therapeutics, INC. | $16.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Najima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.